1,6-Dihydro-7H-pyrrolo[2,3-c]pyridin-7-one, 95.0%, 1g

4-Chloro-3-methylbenzoic Acid>98.0%(GC)(T)5g

(R)-2,5-Ddioxopyrrolidin-1-yl 2-((tert-butoxycarbonyl)amino)-3-phenylpropanoate, 98%, 100g

4-Iodotoluene, 99.0%, 25g

1-(2-Furylmethyl)-4-hydroxy-6-methylpyridin-2(1H)-one, 95.0%, 500mg

(3-Phenyl-1,2,4-oxadiazol-5-yl)methylamine, 95.0%, 100g

2-[(4,5-Dihydro-1H-imidazol-2-yl)amino]ethan-1-ol hydroiodide, 80.0%, 1g

(2S,4S)-4-(((benzyloxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 98%, 500mg

Oprozomib, 99.71%, 5mg

4-Ethynylbenzenesulfonamide>98.0%(HPLC)(N)200mg

tert-butyl (2S)-2-[4-(4-ethynylphenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 100mg

4-Amino-6-chloro-5-methoxypyrimidine, 95.0%, 5g

4-(O-tolyl)butanoic acid, 98+%, 250mg